Evaluation of direct costs associated with alveolar and cystic echinococcosis in Austria.
Felix LötschChristine M BudkeHerbert AuerKlaus KaczirekFredrik WaneckHeimo LaglerMichael RamharterPublished in: PLoS neglected tropical diseases (2019)
This study provides detailed information on direct healthcare-related costs associated with CE and AE in Austria, which may reflect trends for other high-income countries. Surgery and albendazole therapy, due to surprisingly high drug prices, were identified as important cost-drivers. These data will be important for cost-effectiveness analyses of possible prevention programs.
Keyphrases
- healthcare
- minimally invasive
- coronary artery bypass
- physical activity
- electronic health record
- mental health
- health information
- stem cells
- coronary artery disease
- acute coronary syndrome
- mesenchymal stem cells
- percutaneous coronary intervention
- surgical site infection
- deep learning
- cell therapy
- replacement therapy